Why have only a quarter of the 82,000 chemicals in use in the U.S. been tested for toxicity?

• A. Most chemicals are approved without restriction.
• B. Testing is expensive.
• C. Technology has not been sufficient to detect trace amounts.
• D. All of the above.

Answer: (C)

Understanding why only about a quarter of chemicals have toxicity data highlights a fundamental testing bottleneck: detecting harm at very low exposure levels. Toxic effects can occur at trace amounts or after long-term, chronic exposure, and our ability to measure and interpret those subtle effects has historically been limited. If the tools and methods don’t reliably reveal adverse outcomes at those low doses, many chemicals remain untested or only sparsely studied. This limitation in detecting and interpreting low-dose, trace-level effects has been a major reason why comprehensive toxicity testing hasn’t been done for all chemicals, making only a fraction of them well characterized. While cost influences how much testing is done, the specific barrier described here centers on the challenge of identifying toxicity at trace exposures.